AVXL vs. BASI, BCRX, CGEM, TARS, DNA, AUTL, IMTX, RLAY, HUMA, and INBX
Should you be buying Anavex Life Sciences stock or one of its competitors? The main competitors of Anavex Life Sciences include Bioanalytical Systems (BASI), BioCryst Pharmaceuticals (BCRX), Cullinan Therapeutics (CGEM), Tarsus Pharmaceuticals (TARS), Ginkgo Bioworks (DNA), Autolus Therapeutics (AUTL), Immatics (IMTX), Relay Therapeutics (RLAY), Humacyte (HUMA), and Inhibrx (INBX). These companies are all part of the "medical" sector.
Bioanalytical Systems (NASDAQ:BASI) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership, community ranking and profitability.
10.6% of Bioanalytical Systems shares are held by institutional investors. Comparatively, 31.6% of Anavex Life Sciences shares are held by institutional investors. 11.5% of Bioanalytical Systems shares are held by insiders. Comparatively, 11.0% of Anavex Life Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Anavex Life Sciences has a consensus price target of $40.00, suggesting a potential upside of 933.59%. Given Bioanalytical Systems' higher probable upside, analysts clearly believe Anavex Life Sciences is more favorable than Bioanalytical Systems.
Bioanalytical Systems has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Comparatively, Anavex Life Sciences has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500.
In the previous week, Anavex Life Sciences' average media sentiment score of 0.00 equaled Bioanalytical Systems'average media sentiment score.
Anavex Life Sciences received 296 more outperform votes than Bioanalytical Systems when rated by MarketBeat users. Likewise, 74.13% of users gave Anavex Life Sciences an outperform vote while only 41.16% of users gave Bioanalytical Systems an outperform vote.
Bioanalytical Systems has higher revenue and earnings than Anavex Life Sciences. Anavex Life Sciences is trading at a lower price-to-earnings ratio than Bioanalytical Systems, indicating that it is currently the more affordable of the two stocks.
Anavex Life Sciences has a net margin of 0.00% compared to Anavex Life Sciences' net margin of -7.75%. Bioanalytical Systems' return on equity of -29.04% beat Anavex Life Sciences' return on equity.
Summary
Bioanalytical Systems and Anavex Life Sciences tied by winning 7 of the 14 factors compared between the two stocks.
Get Anavex Life Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Anavex Life Sciences Competitors List
Related Companies and Tools
